Literature DB >> 12730693

Deficiency of Mbd2 suppresses intestinal tumorigenesis.

Owen J Sansom1, Jennifer Berger, Stefan M Bishop, Brian Hendrich, Adrian Bird, Alan R Clarke.   

Abstract

Gene silencing through de novo methylation of CpG island promoters contributes to cancer. We find that Mbd2, which recruits co-repressor complexes to methylated DNA, is essential for efficient tumorigenesis in the mouse intestine. As Mbd2-deficient mice are viable and fertile, their resistance to intestinal cancer may be of therapeutic relevance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12730693     DOI: 10.1038/ng1155

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  57 in total

1.  Insights into the role of DNA methylation in disease through the use of mouse models.

Authors:  Melissa Conerly; William M Grady
Journal:  Dis Model Mech       Date:  2010 May-Jun       Impact factor: 5.758

2.  MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties.

Authors:  Xavier Le Guezennec; Michiel Vermeulen; Arie B Brinkman; Wieteke A M Hoeijmakers; Adrian Cohen; Edwin Lasonder; Hendrik G Stunnenberg
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

3.  Giving APCmin tumours a SPARC.

Authors:  Alex Gregorieff; Hans Clevers
Journal:  Gut       Date:  2007-04-19       Impact factor: 23.059

4.  Deficiency of Mbd2 attenuates Wnt signaling.

Authors:  Toby J Phesse; Lee Parry; Karen R Reed; Kenneth B Ewan; Trevor C Dale; Owen J Sansom; Alan R Clarke
Journal:  Mol Cell Biol       Date:  2008-07-21       Impact factor: 4.272

Review 5.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

6.  Overexpression of MBD2 in glioblastoma maintains epigenetic silencing and inhibits the antiangiogenic function of the tumor suppressor gene BAI1.

Authors:  Dan Zhu; Stephen B Hunter; Paula M Vertino; Erwin G Van Meir
Journal:  Cancer Res       Date:  2011-07-01       Impact factor: 12.701

Review 7.  Cancer biology and NuRD: a multifaceted chromatin remodelling complex.

Authors:  Anne Y Lai; Paul A Wade
Journal:  Nat Rev Cancer       Date:  2011-07-07       Impact factor: 60.716

Review 8.  Interplay between the cancer genome and epigenome.

Authors:  Hui Shen; Peter W Laird
Journal:  Cell       Date:  2013-03-28       Impact factor: 41.582

9.  All Things in Moderation: Prevention of Intestinal Adenomas by DNA Hypomethylation.

Authors:  Kwang-Ho Lee; Peter W Laird
Journal:  Cancer Prev Res (Phila)       Date:  2016-05-17

Review 10.  DNA methylation and methyl-CpG binding proteins: developmental requirements and function.

Authors:  Ozren Bogdanović; Gert Jan C Veenstra
Journal:  Chromosoma       Date:  2009-06-09       Impact factor: 4.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.